-
Wisconsin Health Officials Urge Pregnant Women, Elderly to Get RSV Vaccination After Child Deaths -
Children Have Higher Hospitalizations From RSV Than Omicron or Influenza
-
Pfizer Failed to Disclose Risks of Preterm Birth and Neonatal Death to Pregnant Women in RSV Vaccine Trial
-
COVID-19 Is Less Frequent and Severe in Infants Than Other Respiratory Viruses, Study Finds
-
RSV Treatment for Infants in Limited Supply: CDC
-
CDC Warns RSV Cases Are Rising Among Infants, Babies
-
FDA Approves Pfizer’s RSV Vaccine for Pregnant Women
-
Health Canada Approves First RSV Vaccine for Adults Age 60 and Over
-
CDC Recommends Use of Sanofi, AstraZeneca RSV Drug for Infants
-
CDC OKs New Pfizer, GSK Vaccines Against RSV in Older Adults
-
FDA Panel Unanimously Endorses New RSV Antibody Drug for Infants
-
After Decades of Setbacks, First-Ever RSV Vaccine Approved: A Closer Look
-
FDA Approves First-Ever RSV Vaccine for Older Adults
-
FDA Finds Rare Neurological Disorder Is ‘Potential Risk’ With Pfizer RSV Vaccine
-
Respiratory Syncytial Virus–Prevention and Natural Treatments
-
Orange County Issues Emergency Declaration Due to Rising RSV Cases
-
Moderna Begins Late-Stage Study of RSV Vaccine Using mRNA Technology
-
RSV More Prevalent Than COVID-19 in Colorado Children: Chief Medical Officer
